Atai Life Sciences N.V.
(NQ:
ATAI
)
1.080
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Life Sciences N.V.
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
26
27
Next >
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
November 14, 2022
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...
Via
Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
November 10, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05
Via
Benzinga
Atai Life Sciences' Q3 2022 Financials & Business Update, 'Strong Capability To Execute'
November 10, 2022
Clinical-stage psychedelics company atai Life Sciences N.V. (NASDAQ: ATAI) reported its financial results for the quarter ended September 30, 2022 and shared business developments.
Via
Benzinga
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update
November 10, 2022
From
atai Life Sciences
Via
GlobeNewswire
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 09, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14
Via
Benzinga
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
November 07, 2022
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.
Via
Talk Markets
Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More
November 07, 2022
Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'
Via
Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44
Via
Benzinga
These Are The Top Companies And Most Influential People In The Psychedelics Space: Meet The Winners Of The Microdose Awards
November 07, 2022
Which are the top companies and who are the most influential people in the psychedelics space? According to Microdose Psychedelic Insights, host of the Microdose Awards, these are the ones to watch.
Via
Benzinga
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance
November 07, 2022
(Part four of a four-part series) See previous stories in this series:
Via
Benzinga
Women in Psychedelics Announces atai as Platinum Sponsors
November 04, 2022
From
Women in Psychedelics Network
Via
Business Wire
EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'
November 04, 2022
Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a...
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27
Via
Benzinga
New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection
November 03, 2022
Pharmaceutical films leader IntelGenx Corp. (OTCQB: IGXT) filed a provisional patent application with the U.S.
Via
Benzinga
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
November 03, 2022
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis...
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:
Via
Benzinga
Why Shares of atai Life Sciences Climbed 14.58% on Tuesday
November 01, 2022
The company specializes in developing psychedelics as therapies.
Via
The Motley Fool
atai Life Sciences to Participate in November Investor Events & Healthcare Conferences
November 01, 2022
From
atai Life Sciences
Via
GlobeNewswire
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
November 02, 2022
Gainers
Via
Benzinga
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
November 01, 2022
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
Via
Benzinga
atai Life Sciences to Announce Third Quarter 2022 Financial Results and Business Update
November 01, 2022
From
atai Life Sciences
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities
October 31, 2022
(Part one of a four-part series)
Via
Benzinga
A Sinister Reason May Be Behind Governors' Opposition To Cannabis Legalization
October 28, 2022
As one Republican governor after another rejects President Biden’s suggestion to pardon simple cannabis possession convictions, one wonders what they're thinking.
Via
Benzinga
October Recap: Major Psychedelic Drug Stocks Declined 9.9%
October 27, 2022
In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD.
Via
Talk Markets
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
October 27, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87
Via
Benzinga
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
October 26, 2022
Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing...
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
October 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.